Nexstim logo

Nexstim Plc’s Co-operation negotiations concluded

12 September 2016

Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces that it has concluded the co-operation negotiations which started 22 August 2016 with its personnel representatives. As a conclusion, a maximum of 2 employment agreements will be terminated and the maximum of 2 people will be permanently laid off and one person will be working part time in the future.

The negotiations concerned the whole personnel in Finland and are now concluded.


Martin Jamieson, Chairman and CEO



For further information, please visit or contact:


Nexstim                                                                                                    +44 771 516 3942

Martin Jamieson, Chairman and CEO                         


UB Securities Ltd (Certified Adviser)                                                     +358 (0)9 2538 0246


Consilium Strategic Communications                                                    +44 (0)20 3709 5700

Mary-Jane Elliott / Ivar Milligan / Laura Thornton      


About Nexstim Plc


Nexstim is a medical technology company which has pioneered its technology in brain diagnostics with the Navigated Brain Stimulation (NBS) system as the first and only FDA-cleared and CE-marked navigated Transcranial Magnetic Stimulation (nTMS) system for pre-surgical mapping of the motor and speech cortices. Based on the same technology platform, the company has developed a system called Navigated Brain Therapy (NBT®) which is CE-marked for chronic neuropathic pain, major depression and stroke therapy. Nexstim's shares are listed on Nasdaq First North Finland and Nasdaq First North Sweden. For more information please visit

Back to Press Releases